Compile Data Set for Download or QSAR
Report error Found 404 Enz. Inhib. hit(s) with all data for entry = 5943
TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102131(US8530648, 28)
Affinity DataKd:  374nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102132(US8530648, 29)
Affinity DataKd:  360nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102133(CHEMBL2435408 | US8530648, 30)
Affinity DataKd:  630nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102134(US8530648, 31)
Affinity DataKd:  2.06E+3nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102135(US8530648, 32)
Affinity DataKd:  426nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102136(US8530648, 6)
Affinity DataKd:  1.31E+3nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102137(US8530648, 7)
Affinity DataKd: >1.00E+4nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102138(US8530648, 8)
Affinity DataKd:  2.33E+3nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102139(US8530648, 36)
Affinity DataKd:  2.35E+3nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102140(US8530648, 10)
Affinity DataKd:  3.36E+3nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102141(US8530648, 38)
Affinity DataKd: >1.00E+4nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102142(US8530648, 12)
Affinity DataKd: >1.00E+4nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102143(US8530648, 40)
Affinity DataKd:  776nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102144(US8530648, 41)
Affinity DataKd:  1.38E+3nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102145(US8530648, 42)
Affinity DataKd:  1.40E+3nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102151(US8530648, 48)
Affinity DataKd:  3.28E+3nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102152(US8530648, 49)
Affinity DataKd:  1.32E+3nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102153(US8530648, 50)
Affinity DataKd:  4.48E+3nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102154(US8530648, 24)
Affinity DataKd: >1.00E+4nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102155(US8530648, 25)
Affinity DataKd:  5.25E+3nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102157(US8530648, 54)
Affinity DataKd:  702nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102164(US8530648, 61)
Affinity DataKd:  4.32E+3nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102168(US8530648, 75)
Affinity DataKd:  17nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102169(US8530648, 78)
Affinity DataKd:  2.77E+3nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102171(US8530648, 85)
Affinity DataKd:  100nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102172(US8530648, 94)
Affinity DataKd:  36nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102173(US8530648, 97)
Affinity DataKd:  205nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102174(US8530648, 98)
Affinity DataKd:  56nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102176(US8530648, 102)
Affinity DataKd:  1.29E+3nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102306(US8530648, 243)
Affinity DataKd:  318nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102177(US8530648, 107)
Affinity DataKd:  1.84E+3nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102178(US8530648, 111)
Affinity DataKd:  3.26E+3nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102179(US8530648, 50)
Affinity DataKd: >1.00E+4nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102183(US8530648, 120)
Affinity DataKd:  634nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102186(US8530648, 123)
Affinity DataKd:  959nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102189(US8530648, 126)
Affinity DataKd:  728nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102190(US8530648, 127)
Affinity DataKd:  2.05E+3nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102192(US8530648, 129)
Affinity DataKd:  3.82E+3nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102194(US8530648, 131)
Affinity DataKd:  1.86E+3nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102202(US8530648, 139)
Affinity DataKd:  1.15E+3nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102206(US8530648, 143)
Affinity DataKd:  2.33E+3nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102211(US8530648, 148)
Affinity DataKd:  5.09E+3nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102212(US8530648, 149)
Affinity DataKd:  2.76E+3nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102224(US8530648, 161)
Affinity DataKd:  429nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102227(US8530648, 164)
Affinity DataKd:  980nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102233(US8530648, 170)
Affinity DataKd:  4.58E+3nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102240(US8530648, 177)
Affinity DataKd:  3.82E+3nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102242(US8530648, 179)
Affinity DataKd:  3.51E+3nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102254(US8530648, 191)
Affinity DataKd:  4.99E+3nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102257(US8530648, 194)
Affinity DataKd: >1.00E+4nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
Go to US Patent

Displayed 1 to 50 (of 404 total ) | Next | Last >>
Jump to: